Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:0... (turing facilities and an R&D platform su...)

HOME >> BIOLOGY >> TECHNOLOGY

Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST

Date:10/27/2008

turing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 48 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 720 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 1,384 employees. Tianyin achieved revenue of approximately $33.5 million and net income of approximately $6 million in FY2008 ending June 30, 2008. For more information about Tianyin, please visit http://www.tianyinpharma.com

Safe Harbor Statement

This Press Release contains or may contain forward looking statements and information that are based upon beliefs of and information currently available to the Company's management as well as estimates and assumptions made by the Company's management. When used herein the words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan" and similar expressions as they relate to the Company or the Company's management identify forward looking statements. These statements involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, intended or planned.

For more information, please contact:

For the Company:

Allen Tang, Ph.D., MBA, Assistant to the CEO

China 1582122564
'/>"/>

SOURCE Tianyin Pharmaceutical (TPI)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
2. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
5. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
6. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
7. BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
8. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
9. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
10. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
11. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights

Post Your Comments:

(Date:12/15/2009)... The Center for Business Intelligence (CBI), a ... announce the full agenda for the ... . The forum will take place at ... ,, Over 1,500 senior-level Finance, Accounting, Audit ... event since its inception, and this year,s ...

(Date:12/15/2009)... has announced the launch of several innovative new programs ... in the current economic climate. The first is ... finance legal services over a period of 6, 12, ... their start-up companies. The second is aimed at ... arrangements over 6 to 12 month period at discounted ...

(Date:12/14/2009)... Patrick Kennedy Joins with State Biotech Leaders ... in Research and Development while Boosting Rhode ... ,, PROVIDENCE, R.I., Dec. 14 /PRNewswire-USNewswire/ ... leaders in research, medicine and biotechnology gathered ... to discuss the importance of medical innovation ...

(Date:12/14/2009)... -- Nektar Therapeutics (Nasdaq: NKTR ) announced ... serve on its board of directors. Winger ... 35 years of experience in corporate management, financial ... extensive industry perspective at an important time in ... and CEO of Nektar and member of the ...

Breaking Biology Technology:CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2 The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2 Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2 Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3 Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4 Dennis Winger Joins Nektar Therapeutics' Board of Directors 2 Dennis Winger Joins Nektar Therapeutics' Board of Directors 3

[0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress [0] The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses [0] Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation'[0] Dennis Winger Joins Nektar Therapeutics' Board of Directors

... MORRISTOWN, N.J., March 26 Vicus Therapeutics, ... K. Rao, Vice President Clinical Research and ... Institute,s 15th International,Molecular Medicine Tri-Conference on March ... North Convention Center in San Francisco. Dr. ...

... (Nasdaq: TPTX ) today announced financial results for ... the full year 2007,the Company posted revenue of $9.9 ... cash equivalents totaled $32.5 million at December 31, 2007., ... development programs,in 2007," said Neil Kurtz, M.D., President and ...

... PHST ), a leading provider of software, strategic,consulting, ... that it will be presenting at B. Riley & ... 2008 at the Palms Las,Vegas. Shawn O,Connor, Pharsight,s President ... will be presenting on April 2nd,at 1:30 p.m. PT., ...

Other Biology Technology:TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 2 TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 3 TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 4 TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 5 TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 6 TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 7 Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference 2

Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference

(Date:12/15/2009)... WI, December 15, 2009 Economics, environmental impacts, ... factors that influence the overall success of an ... on the system, forcing individuals and social groups ... order to survive. , Experiential learning theory ... result of firsthand experiences. Such lessons are especially ...

(Date:12/15/2009)... ancient American horses may have been grazing the ... than previously thought. After plucking ancient DNA from ... researchers used cutting-edge techniques to uncover "genetic fossils" ... to between 7,600 and 10,500 calendar years. This ... of these now-extinct mammals endured longer in the ...

(Date:12/15/2009)... German . , Leipzig: Species distribution models are ... of mammals. This is the finding of a study ... The researchers analysed data on species distribution, climate, land ... of the species. Judging by the large differences in ... to adapt fast to changing climatic conditions. This in ...

Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2 Late-surviving megafauna exposed by ancient DNA in frozen soil 2 Late-surviving megafauna exposed by ancient DNA in frozen soil 3 Late-surviving megafauna exposed by ancient DNA in frozen soil 4 Species distribution models are of only limited value for predicting future mammal distributions 2 VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 1 VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 2 VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 3 Americans Spend Billions on Alternative Medicine 53255 1 Americans Spend Billions on Alternative Medicine 53255 2 Americans Spend Billions on Alternative Medicine 53255 3 FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 1 FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 2 FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 3 FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 4

[0] Experiential learning teaches change and adaptation [0] Late-surviving megafauna exposed by ancient DNA in frozen soil [0] Species distribution models are of only limited value for predicting future mammal distributions

... biological attributes, is shaped by evolution through environmental ... are in other ways very similar might respond ... world slightly differently, using photoreceptors that are attuned ... special group of closely-related fish species inhabiting the ...

... By investigating the interplay between pheromone signaling and behavior ... an adult fly's earlier experience as a young individual ... adult. In particular, the researchers found that pheromone signals ... influence how young flies will behave once they reach ...

... tetrahydrocannabinol--has a well-documented tendency to stimulate hunger. ... to cannabinoid receptors in the brain, they ... circuitry underlying this effect. , Understanding this ... the cannabinoid receptor, CB1, offers a promising ...

Other Biology News:Multiple genes permit closely related fish species to mix and match their color vision 2 Past experience of pheromones induces dominant courtship behavior in fruit flies 2 Machinery of the 'marijuana munchies' 2

Multiple genes permit closely related fish species to mix and match their color vision Past experience of pheromones induces dominant courtship behavior in fruit flies Machinery of the 'marijuana munchies'

...

... designed to rapidly and reliably amplify ... patented APA Technology. APAgene provides hassle-free, ... competitive price. All necessary ingredients are ... Kit can be used for identifying ...

... designed to deparaffinize and perform Heat Induced ... tissue sections mounted on glass microscope slides. ... at the high temperature used in HIER ... the paraffin by detergent. Formaldehyde fixation impairs ...

Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...

Biology Products:

Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion APAgene Locator Kit from Bio S&T PT Module^TM Deparaffinization and Heat-Induced Epitope Retrieval Solution (10X) from Lab Vision Chicken Anti-Bacterial ytzF Polyclonal Antibody, Unconjugated from Abcam

Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:0...(turing facilities and an R&D platform su...)